HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hans Ivers Selected Research

Sleep Initiation and Maintenance Disorders (Insomnia)

1/2022Does total sleep time substantially increase after cognitive behavioral therapy for insomnia?
11/2021Efficacy of a stepped care approach to deliver cognitive-behavioral therapy for insomnia in cancer patients: a noninferiority randomized controlled trial.
1/2021Feasibility of a Preventive Intervention for Insomnia in Women with Breast Cancer Receiving Chemotherapy.
1/2021Prospective Rates, Longitudinal Associations, and Factors Associated With Comorbid Insomnia Symptoms and Perceived Cognitive Impairment.
12/2020Insomnia, hypnotic use, and road collisions: a population-based, 5-year cohort study.
11/2020Effectiveness of Sequential Psychological and Medication Therapies for Insomnia Disorder: A Randomized Clinical Trial.
9/2020Clusters of Psychological Symptoms in Breast Cancer: Is There a Common Psychological Mechanism?
5/2020Insomnia, immunity, and infections in cancer patients: Results from a longitudinal study.
3/2020Correlates of disrupted sleep-wake variables in patients with advanced cancer.
10/2019Screening for clinical insomnia in cancer patients with the Edmonton Symptom Assessment System-Revised: a specific sleep item is needed.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hans Ivers Research Topics

Disease

38Sleep Initiation and Maintenance Disorders (Insomnia)
01/2022 - 02/2005
18Neoplasms (Cancer)
11/2021 - 07/2009
14Breast Neoplasms (Breast Cancer)
01/2021 - 09/2005
5Fatigue
09/2020 - 11/2005
5Prostatic Neoplasms (Prostate Cancer)
12/2017 - 02/2005
4Cognitive Dysfunction
01/2021 - 07/2009
4Pain (Aches)
09/2020 - 02/2005
2Infections
01/2021 - 05/2020
2Sleep Wake Disorders
12/2018 - 01/2011
2Schizophrenia (Dementia Praecox)
01/2017 - 01/2016
2Hot Flashes
08/2015 - 09/2011
1Mental Disorders (Mental Disorder)
11/2020
1Major Depressive Disorder (Major Depressive Disorders)
08/2019
1Disorders of Excessive Somnolence (Hypersomnia)
12/2018
1Wounds and Injuries (Trauma)
01/2017
1Medically Unexplained Symptoms
05/2015
1Head and Neck Neoplasms (Head and Neck Cancer)
04/2013

Drug/Important Bio-Agent (IBA)

7Hypnotics and Sedatives (Sedatives)IBA
12/2020 - 09/2005
4Zolpidem (Ambien)FDA LinkGeneric
11/2020 - 06/2014
4AndrogensIBA
05/2015 - 02/2005
3Antidepressive Agents (Antidepressants)IBA
01/2021 - 01/2018
2Anti-Anxiety Agents (Anxiolytics)IBA
01/2021 - 01/2018
2Hormones (Hormone)IBA
05/2015 - 04/2009
2N 30IBA
09/2005 - 09/2005
1Biomarkers (Surrogate Marker)IBA
01/2021
1Trazodone (Trittico)FDA LinkGeneric
11/2020
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
10/2019
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
08/2019
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
08/2019
1Biological ProductsIBA
02/2017
1cytidylyl-(3'-5')-cytidine (CpC)IBA
10/2016
1GABA-A Receptors (GABA(A) Receptor)IBA
03/2016
1Aligeron (AS 2)IBA
10/2015
1Estrogens (Estrogen)FDA Link
08/2015
1morinIBA
08/2014
1SolutionsIBA
11/2010

Therapy/Procedure

18Therapeutics
01/2022 - 04/2009
11Drug Therapy (Chemotherapy)
01/2021 - 04/2009
8Radiotherapy
09/2020 - 11/2005
3Palliative Care (Palliative Therapy)
03/2020 - 01/2018
3Prostatectomy (Retropubic Prostatectomy)
12/2017 - 02/2005
3Perioperative Period
07/2017 - 05/2015
2Phototherapy (Light Therapy)
08/2019 - 01/2018
1Complementary Therapies (Alternative Medicine)
01/2018
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2011
1Brachytherapy
11/2005